Navigation Links
Cancer Cells May Be Able to Urge Their Own Death
Date:12/22/2010

WEDNESDAY, Dec. 22 (HealthDay News) -- New research suggests that many cancer cells are equipped with a kind of suicide pill: a protein on their surfaces that gives them the ability to send an "eat me" signal to immune cells.

The challenge now, the researchers say, is to figure out how to coax cancer cells into emitting the signal rather than a dangerous "don't eat me" signal.

A study published online Dec. 22 in Science Translational Medicine reports that the cells send out the enticing "eat me" signal by displaying the protein calreticulin. But another molecule, called CD47, allows most cancer cells to avoid destruction by sending the opposite signal: "Don't eat me."

In earlier research, Stanford University School of Medicine scientists found that an antibody that blocks CD47 -- turning off the signal -- could help fight cancer, but mysteries remained.

"Many normal cells in the body have CD47, and yet those cells are not affected by the anti-CD47 antibody," Mark Chao, a Stanford graduate student and the study's lead author, said in a university news release. "At that time, we knew that anti-CD47 antibody treatment selectively killed only cancer cells without being toxic to most normal cells, although we didn't know why."

Now, the new research has shown that calreticulin exists in a variety of cancers, including some types of leukemia, non-Hodgkin's lymphoma and bladder, brain and ovarian cancers. "This research demonstrates that the reason that blocking the CD47 'don't eat me' signal works to kill cancer is that leukemias, lymphomas and many solid tumors also display a calreticulin 'eat me' signal," Dr. Irving Weissman, director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine and a co-principal investigator of the study, said in the release. "The research also shows that most normal cell populations don't display calreticulin and are, therefore, not depleted when we expos
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Enhancing arrest of cell growth to treat cancer in mice
2. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
3. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
4. Low forms of cyclin E reduce breast cancer drugs effectiveness
5. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
6. Soft drinks may increase risk of pancreatic cancer
7. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
8. Genes Play Role in Prognosis With Non-Small Cell Lung Cancers
9. Single gene mutation induces endometrial cancer
10. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
11. Molecular pathways linked to sex, age affect outcomes in lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Cells May Be Able to Urge Their Own Death
(Date:5/26/2015)... Phoenix, AZ (PRWEB) May 26, 2015 Beloved ... its innovative sixty minutes or less drain clog guarantee or ... discounts all of which can be found here . ... which has played no small part in the company’s rich ... less drain clog guarantee covers every drain clog imaginable. Whether ...
(Date:5/26/2015)... Now offering innovative, safe, and effective hair ... Dr. Hedi Belajouza in Tunisia extends the boundaries ... the last detail — meticulous hair placement, artistic shape ... harvested follicle — are all results in exceptionally satisfied ... the artistry and talent of Tunisian hair transplant surgeon, ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Sexual harassment and ... Title IX is best known for creating opportunities in women's ... for sexual assault response and prevention. In a recent episode ... Global Sports Advocates explains what Title IX means for ... get in front of this issue to protect students. , ...
(Date:5/26/2015)... 26, 2015 Irwin Gross, M.D., ... a hospital-wide Patient Blood Management (PBM) initiative at Eastern ... blood usage by more than 60 percent and improved ... in detail in an article in the May 2015 ... reduced perioperative red cell loss, less acute kidney injury ...
(Date:5/26/2015)... Angeles, CA (PRWEB) May 26, 2015 ... Center recently joined Dr. Marissa Pei on ... union” conversation focusing on addiction. Aired on KCAA AM ... and Deena Duncan, marriage and family therapist, as they ... is estimated to affect more than 23.5 million Americans. ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Offers Special, Sixty Minute Drain Clean Guarantee or Else It’s on Them 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 2Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 3Health News:Hair Transplant Center in Tunisia Now Offering Innovative Restoration Technology 4Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3
... (TSXV:MFS) announced that positive clinical results when using the ... the treatment of early stage breast cancer tumors, were ... the Toronto Stock Exchange on March 25, 2009 and ... held March 14-18, 2009 in Las Vegas, Nevada. The ...
... Pleads Guilty to Felony Misbranding WASHINGTON, April 15 ... Institute Diagnostics (NID), have entered into a global ... and civil claims concerning various types of diagnostic ... to laboratories throughout the country until 2006, the ...
... Program Use Vary in EffectivenessWASHINGTON, April 15 ... benefit programs, companies continue to add wellness and ... their workers. Additionally, companies are finding greater success ... these programs, according to a survey by Watson ...
... ability to diagnose the disease, , , WEDNESDAY, April ... could help improve the tracking of changes in ... University School of Medicine. , The technology uses ... of features in or on a single cell. ...
... 2009 -- Sleep is such an essential part of human ... doing it -- some more successfully than others. Sleep disorders ... are a major cause of disease and injury. People who ... attack, stroke, hypertension, obesity, depression, and accidents. Nearly a fifth ...
... April 15 On April 1, 2009, Hospices around ... all those individuals that volunteer in Hospice. The ... Administrative Volunteer, Patient Care Volunteer and Lifetime Achievement. ... a Visionary Award Winner (an individual not directly connected ...
Cached Medicine News:Health News:Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors 2Health News:Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors 3Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 2Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 3Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 4Health News:Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds 2Health News:Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds 3Health News:New way to analyze sleep disorders 2Health News:New way to analyze sleep disorders 3
(Date:5/26/2015)... 26, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  ... Officer, will be making a presentation on PAREXEL and ... June 9, 2015. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
(Date:5/26/2015)... 26, 2015 Cellular testing ... ,What,s the future of technologies for screening cells? ... 2015. Stay ahead there for data, benefiting your ... results, R&D, opportunities and revenue forecasts. ... you what,s possible for cell-based assays ...
(Date:5/26/2015)... -- ViiV Healthcare, Aurobindo Pharma, and the ... Aurobindo Pharma has submitted an Abbreviated New Drug Application ... Food and Drug Administration (FDA), for the treatment of ... version of dolutegravir, less than two years after FDA ... the United States . Upon receiving ...
Breaking Medicine Technology:PAREXEL International To Present At Goldman Sachs Healthcare Conference 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7
...   Prasco® Laboratories announced today it has entered into ... ) for the distribution in the U.S. of ... (Carbamazepine) Extended-Release Capsules in 100 mg, 200 mg and ... are AB-rated, therapeutically equivalent and substitutable for the brand ...
... 2012  The Board of Directors of MiMedx Group, Inc. (OTCBB: ... supports the Company,s Chairman and CEO, Parker H. "Pete" ... Exchange Commission ("SEC"). The SEC has ... in 2007, when he was Chairman and CEO of ...
Cached Medicine Technology:Prasco® Launches Authorized Generic of Shire's Carbatrol® 2Prasco® Launches Authorized Generic of Shire's Carbatrol® 3Prasco® Launches Authorized Generic of Shire's Carbatrol® 4MiMedx Group, Inc. Board Announces Support for Chairman Parker H. "Pete" Petit 2
Cold light source triple outlet....
Cold light source single outlet....
The 9100 is a truly affordable 100 Watt xenon light source providing accurate color and brightness. This xenon light source is ideal for surgery centers, evaluations or general office use....
The Carl Zeiss Head-worn Loupes L and LC are the ideal solution if a low magnification suffices for your work and you want to keep your hands free to perform the task at hand....
Medicine Products: